Apalutamide 240mg tablets
NHS hospitals in England used £88,335,518 of indicative cost of Apalutamide 240mg tablets in the 12 months to July 2026, about 0.3% of all hospital medicines spend. That is up 159.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Apalutamide 240mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Apalutamide 240mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £12,095,244 |
| The Royal Marsden Nhs Foundation Trust | £6,743,826 |
| Sheffield Teaching Hospitals Nhs Trust | £5,104,878 |
| Norfolk & Norwich University Hpl Nhs Trt | £4,661,808 |
| Derby Teaching Hospitals Nhs Found Trust | £4,346,013 |
| The Christie Nhs Foundation Trust | £4,269,726 |
| Univ Hpl B/Ham Nhs Foundation Trust | £3,246,445 |
| East And North Hertfordshire Nhs Trust | £3,238,240 |
| Guy's & St Thomas' Nhs Foundation Trust | £2,983,885 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £2,951,065 |
The primary-care picture
Apalutamide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Apalutamide medicine page.